Yen-Chao Wang

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation

Yen-Chao Wang, Gladys Morrison, Ryan Gillihan et al. · Breast Cancer Research · 2011 · 283 citations · Full text

Medicine, Oncology, Pharmacology +17

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

Catherine Huang, Catherine C. Park, Susan G. Hilsenbeck et al. · Breast Cancer Research · 2011 · 163 citations · Full text

Medicine, Oncology, Pharmacology +16

Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

Mario Giuliano, Huizhong Hu, Yen-Chao Wang et al. · Clinical Cancer Research · 2015 · 119 citations · Full text

Medicine, Cancer Biology, Oncology +14

Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/<i>neu</i>-Overexpressing Breast Tumor Xenografts

Mothaffar F. Rimawi, Lisa Wiechmann, Yen-Chao Wang et al. · Clinical Cancer Research · 2010 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies

Albert C. Chen, Ilenia Migliaccio, Mothaffar F. Rimawi et al. · Breast Cancer Research and Treatment · 2012 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +13